Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Prognostic relevance of BRD7 expression in colorectal carcinoma.

Wu WJ, Hu KS, Chen DL, Zeng ZL, Luo HY, Wang F, Wang DS, Wang ZQ, He F, Xu RH.

Eur J Clin Invest. 2013 Feb;43(2):131-40. doi: 10.1111/eci.12024. Epub 2012 Dec 7.

PMID:
23215825
2.

Prognostic relevance of melanoma antigen D1 expression in colorectal carcinoma.

Zeng ZL, Wu WJ, Yang J, Tang ZJ, Chen DL, Qiu MZ, Luo HY, Wang ZQ, Jin Y, Wang DS, Xu RH.

J Transl Med. 2012 Aug 31;10:181. doi: 10.1186/1479-5876-10-181.

3.

Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma.

Cao JY, Liu L, Chen SP, Zhang X, Mi YJ, Liu ZG, Li MZ, Zhang H, Qian CN, Shao JY, Fu LW, Xia YF, Zeng MS.

Mol Cancer. 2010 Sep 9;9:237. doi: 10.1186/1476-4598-9-237.

4.

[Expression and clinical significance of bromodomain-containing protein 7 in non-small cell lung cancer].

Chen L, Yu F.

Zhongguo Fei Ai Za Zhi. 2011 Oct;14(10):830-4. doi: 10.3779/j.issn.1009-3419.2011.10.11. Chinese.

5.

Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.

Shi H, Zhou Y, Liu H, Chen C, Li S, Li N, Li X, Zhang X, Zhang H, Wang W, Zhao Q.

BMC Cancer. 2010 Sep 3;10:477. doi: 10.1186/1471-2407-10-477.

6.

Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.

Feng B, Xu WB, Zheng MH, Ma JJ, Cai Q, Zhang Y, Ji J, Lu AG, Qu Y, Li JW, Wang ML, Hu WG, Liu BY, Zhu ZG.

J Gastroenterol Hepatol. 2006 Oct;21(10):1596-603.

PMID:
16928223
7.

Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.

Liao WT, Wang X, Xu LH, Kong QL, Yu CP, Li MZ, Shi L, Zeng MS, Song LB.

Cancer. 2009 Apr 1;115(7):1507-17. doi: 10.1002/cncr.24128.

8.

GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer.

Li H, Guo L, Chen SW, Zhao XH, Zhuang SM, Wang LP, Song LB, Song M.

J Transl Med. 2012 Aug 20;10:168. doi: 10.1186/1479-5876-10-168.

9.

Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.

Li X, Wang J, Zhang X, Zeng Y, Liang L, Ding Y.

Ann Surg Oncol. 2012 Jan;19(1):145-53. doi: 10.1245/s10434-011-1944-4. Epub 2011 Aug 23.

PMID:
21861235
10.

Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma.

Park YA, Lee JW, Kim HS, Lee YY, Kim TJ, Choi CH, Choi JJ, Jeon HK, Cho YJ, Ryu JY, Kim BG, Bae DS.

Clin Cancer Res. 2014 Feb 1;20(3):565-75. doi: 10.1158/1078-0432.CCR-13-1271. Epub 2013 Nov 6.

11.

Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma.

Chen CL, Wang Y, Pan QZ, Tang Y, Wang QJ, Pan K, Huang LX, He J, Zhao JJ, Jiang SS, Zhang XF, Zhang HX, Zhou ZQ, Weng de S, Xia JC.

Oncotarget. 2016 Mar 29;7(13):16248-61. doi: 10.18632/oncotarget.7637.

12.

Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.

Tu L, Liu Z, He X, He Y, Yang H, Jiang Q, Xie S, Xiao G, Li X, Yao K, Fang W.

Mol Cancer. 2010 Apr 16;9:78. doi: 10.1186/1476-4598-9-78.

13.

Loss of anterior gradient-2 expression is an independent prognostic factor in colorectal carcinomas.

Riener MO, Thiesler T, Hellerbrand C, Amann T, Cathomas G, Fritzsche FR, Dahl E, Bahra M, Weichert W, Terracciano L, Kristiansen G.

Eur J Cancer. 2014 Jul;50(10):1722-30. doi: 10.1016/j.ejca.2014.04.012. Epub 2014 Apr 30.

PMID:
24794000
14.

Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.

Lu Y, Jingyan G, Baorong S, Peng J, Xu Y, Cai S.

Cancer Biomark. 2012;11(5):219-26. doi: 10.3233/CBM-2012-00282.

PMID:
23220854
15.

High expression of CD73 as a poor prognostic biomarker in human colorectal cancer.

Wu XR, He XS, Chen YF, Yuan RX, Zeng Y, Lian L, Zou YF, Lan N, Wu XJ, Lan P.

J Surg Oncol. 2012 Aug 1;106(2):130-7. doi: 10.1002/jso.23056. Epub 2012 Jan 27.

PMID:
22287455
16.

Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.

Yang C, Wen Y, Li H, Zhang D, Zhang N, Shi X, Jiang B, Ma X, Yang P, Tang H, Peng Z, Yang Y.

Oncol Rep. 2012 Jan;27(1):135-42. doi: 10.3892/or.2011.1473. Epub 2011 Sep 22.

PMID:
21947329
17.

High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.

Shubbar E, Helou K, Kovács A, Nemes S, Hajizadeh S, Enerbäck C, Einbeigi Z.

BMC Cancer. 2013 Feb 1;13:47. doi: 10.1186/1471-2407-13-47.

18.

Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma.

Zhang Z, Li J, Zheng H, Yu C, Chen J, Liu Z, Li M, Zeng M, Zhou F, Song L.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2685-93. doi: 10.1158/1055-9965.EPI-09-0097. Epub 2009 Sep 15.

19.

Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.

He WL, Li YH, Yang DJ, Song W, Chen XL, Liu FK, Wang Z, Li W, Chen W, Chen CY, He YL, Zhan WH.

Eur J Surg Oncol. 2013 Feb;39(2):141-9. doi: 10.1016/j.ejso.2012.08.023. Epub 2012 Sep 19.

PMID:
22999412
20.

Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer.

Zhang XM, Wang XY, Sheng SR, Wang JR, Li J.

World J Gastroenterol. 2003 Aug;9(8):1729-33.

Supplemental Content

Support Center